Can Medical Cannabis Heal Anxiety? What One Year Shows
Anxiety disorders affect over 300 million people worldwide and are among the most common reasons individuals seek mental health treatment. However, standard options like SSRIs and benzodiazepines don’t work for everyone and often come with side effects that prompt people to look for alternatives. Medical cannabis has emerged as a promising option and is actively being studied for its long-term effects. What do we already know?
A Growing Area of Cannabis Research
In the last decade, public perception and legal regulation of cannabis have shifted dramatically. As medical programs expand and stigma fades, more researchers are turning their attention to how cannabis compounds — especially CBD and THC — affect anxiety symptoms. Studies are no longer just asking if cannabis helps with anxiety, but how, for whom, and under what conditions.
CBD in particular has shown potential as an anxiolytic (which means anxiety-reducing or calming), while THC’s effects remain more complex — relaxing at low doses, potentially anxiety-inducing at higher ones. Researchers are exploring how these compounds interact, what dosing matters most, and whether delivery method (oil, vapor, capsule) affects outcomes.
12 Months of Cannabis Treatment: What Patients Report
A major Australian study, published in April 2025 in the open-access journal PLOS ONE by researchers from the University of Sydney, suggests cannabis does its job. Known as the QUEST Initiative (QUality of life Evaluation STudy), the research tracked 2,353 adults prescribed cannabis oil for conditions such as anxiety, depression, chronic pain, and insomnia. After one year, many participants reported ongoing improvements in sleep, mood, energy levels, and overall quality of life.
Patients with generalized anxiety disorder (GAD), PTSD, and chronic insomnia reported reduced symptoms and improved emotional and cognitive function. These benefits — first noticeable at the 3-month mark — were maintained through the 12-month follow-up. Importantly, the cannabis oil used came from standardized sources, helping reduce inconsistencies in dosing.
However, the study also had limitations. There was no control group, and only 778 people (33%) completed the full 12-month survey. That means we can’t say for certain that cannabis alone caused the improvements. Still, for patients not responding to conventional treatments, this large-scale, real-world data adds weight to growing interest in cannabis-based mental health support.
Where the Science Still Stumbles
While studies like QUEST offer hopeful signs, they also underscore the need for more rigorous science. That’s precisely what a May 2025 systematic review by researchers from The University of Western Australia, published in Psychiatry Research, set out to examine.
Reviewing 57 peer-reviewed studies focused exclusively on medicinal cannabis and anxiety-related disorders in adults, the review offers a mixed picture. Only 30% of the studies were randomized controlled trials (RCTs), while 40% were cohort studies, 18% cross-sectional, and 12% qualitative or other designs.
The average study quality score on the MASTER scale (Methodological Standard for Epidemiological Research) was 62.9 out of 100, indicating a notable risk of bias—often due to inadequate reporting or inconsistent study design. For instance, nearly half of the studies either failed to specify the form and dosage of cannabis used or relied entirely on participants’ self-reported use.
Even so, among the 13 highest-quality studies, 70% reported clear positive outcomes for anxiety-related conditions such as generalized anxiety disorder, post-traumatic stress disorder, and social anxiety disorder. That’s a strong signal in favor of cannabis’s therapeutic potential for some of the most prevalent and disruptive forms of anxiety.
The other 30% of high-quality studies didn’t show clear or consistent benefits. This was especially true for less common or more specific conditions — like obsessive-compulsive disorder (OCD), anxiety triggered by exams or performance situations (known as test anxiety), and trichotillomania, a condition where people feel the urge to pull out their own hair. These mixed results suggest that while medicinal cannabis may help with some types of anxiety, more focused research is still needed for these narrower and often more complex cases.
A Promising Path of Medical Cannabis
The rising use of medicinal cannabis for anxiety isn’t just a trend — it’s a reflection of patient need, shifting cultural attitudes, and scientific curiosity. Real-world studies like QUEST suggest cannabis may help with anxiety, sleep, and quality of life, especially for those who haven’t found relief elsewhere.
But science moves slower than public interest. As the 2025 systematic review shows, much of the current research is still too inconsistent to guide clinical decision-making with confidence. The challenge now is to match growing demand with better data.
Medicinal cannabis is not a magic pill. But with standardized trials, clearer dosing guidelines, and long-term follow-up, it could become a more established and responsible option in the evolving mental health toolkit.
Choose the Type of Support That Matches Your Need
United Kingdom A medical cannabis clinic combining technology and tailored medical care, providing affordable access to innovative treatments
United Kingdom A private, patient-centered medical cannabis provider known for its high-touch approach and transparent fees
United Kingdom Lyphe Clinic provides medical cannabis consultations and prescriptions through a digitally driven patient platform, making treatments convenient and accessible
